UCB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 124.6 EUR | +0.81% |
|
+2.09% | +57.86% |
| 04-11 | Berenberg Reiterates UCB's Purchase Rating, Raises PT | MT |
| 04-11 | UCB : Berenberg, Buy, raises its price target | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 25.12B | ||||||
| 87.17B | ||||||
| 40.1B | ||||||
| 31.38B | ||||||
| 15.59B | ||||||
| 12B |
- Stock Market
- Equities
- UCB Stock
- Charts UCB
- Sector Chart
